CVAC logo

CureVac N.V. (CVAC) Cash and Cash Equivalents

Annual Cash & Cash Equivalents:

$501.29M+$56.42M(+12.68%)
December 31, 2024

Summary

  • As of today, CVAC annual cash & cash equivalents is $501.29 million, with the most recent change of +$56.42 million (+12.68%) on December 31, 2024.
  • During the last 3 years, CVAC annual cash & cash equivalents has fallen by -$417.46 million (-45.44%).
  • CVAC annual cash & cash equivalents is now -69.18% below its all-time high of $1.63 billion, reached on December 31, 2020.

Performance

CVAC Cash and Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACbalance sheet metrics

Quarterly Cash & Cash Equivalents:

$488.91M+$27.93M(+6.06%)
September 1, 2025

Summary

  • As of today, CVAC quarterly cash & cash equivalents is $488.91 million, with the most recent change of +$27.93 million (+6.06%) on September 1, 2025.
  • Over the past year, CVAC quarterly cash & cash equivalents has dropped by -$125.88 million (-20.48%).
  • CVAC quarterly cash & cash equivalents is now -69.80% below its all-time high of $1.62 billion, reached on December 31, 2020.

Performance

CVAC Quarterly Cash & Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACbalance sheet metrics

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

CVAC Cash and Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+12.7%-20.5%
3Y3 Years-45.4%-7.7%
5Y5 Years+1358.5%-53.3%

CVAC Cash and Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-45.4%+12.7%-27.1%+125.3%
5Y5-Year-69.2%+1358.5%-69.8%+125.3%
All-TimeAll-Time-69.2%+1949.7%-69.8%+1322.4%

CVAC Cash and Cash Equivalents History

DateAnnualQuarterly
Sep 2025
-
$488.91M(+6.1%)
Jun 2025
-
$460.97M(-2.6%)
Mar 2025
-
$473.49M(-5.1%)
Dec 2024
$501.29M(+12.7%)
$498.85M(-18.9%)
Sep 2024
-
$614.79M(+183.3%)
Jun 2024
-
$217.05M(-33.0%)
Mar 2024
-
$324.16M(-27.1%)
Dec 2023
$444.87M(-16.3%)
$444.57M(-9.5%)
Sep 2023
-
$491.41M(-16.3%)
Jun 2023
-
$586.88M(-12.5%)
Mar 2023
-
$670.90M(+26.8%)
DateAnnualQuarterly
Dec 2022
$531.69M(-42.1%)
$529.14M(-0.1%)
Sep 2022
-
$529.86M(-11.6%)
Jun 2022
-
$599.63M(-18.1%)
Mar 2022
-
$732.35M(-20.6%)
Dec 2021
$918.76M(-43.5%)
$922.80M(-25.5%)
Sep 2021
-
$1.24B(-23.5%)
Dec 2020
$1.63B(+4632.8%)
$1.62B(+54.7%)
Sep 2020
-
$1.05B(+2093.8%)
Mar 2020
-
$47.70M(+38.8%)
Dec 2019
$34.37M(+40.5%)
$34.37M
Dec 2018
$24.46M
-

FAQ

  • What is CureVac N.V. annual cash & cash equivalents?
  • What is the all-time high annual cash & cash equivalents for CureVac N.V.?
  • What is CureVac N.V. annual cash & cash equivalents year-on-year change?
  • What is CureVac N.V. quarterly cash & cash equivalents?
  • What is the all-time high quarterly cash & cash equivalents for CureVac N.V.?
  • What is CureVac N.V. quarterly cash & cash equivalents year-on-year change?

What is CureVac N.V. annual cash & cash equivalents?

The current annual cash & cash equivalents of CVAC is $501.29M

What is the all-time high annual cash & cash equivalents for CureVac N.V.?

CureVac N.V. all-time high annual cash & cash equivalents is $1.63B

What is CureVac N.V. annual cash & cash equivalents year-on-year change?

Over the past year, CVAC annual cash & cash equivalents has changed by +$56.42M (+12.68%)

What is CureVac N.V. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of CVAC is $488.91M

What is the all-time high quarterly cash & cash equivalents for CureVac N.V.?

CureVac N.V. all-time high quarterly cash & cash equivalents is $1.62B

What is CureVac N.V. quarterly cash & cash equivalents year-on-year change?

Over the past year, CVAC quarterly cash & cash equivalents has changed by -$125.88M (-20.48%)
On this page